Note: Rite-Value Pharmacy's revenues are gauged from an analysis of company filings.
Rite-Value Pharmacy's Income Statement (based on Industry Averages)
Rite-Value Pharmacy P&L
$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Trademark Applications
Trademark applications show the products and services that Rite-Value Pharmacy is developing and marketing.
Rite-Value Pharmacy doesn't have any recent trademark applications, indicating Rite-Value Pharmacy is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
LIFE PILLARS Securities brokerage; financial investment and financial advisory services
12/27/2023
THE KEY TO BEING RICH IS KNOWING WHAT TO COUNT Securities brokerage; financial investment and financial advisory services
12/17/2023
FIND YOUR RICH Securities brokerage; financial investment and financial advisory services
12/17/2023
See all trademarks and details in the Full Report.
Market Share of Rite-Value Pharmacy's Largest Competitors
A competitive analysis shows these companies are in the same general field as Rite-Value Pharmacy, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are in the same general field as Rite-Value Pharmacy and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.